Archives
FDA Approves Eli Lilly's Alzheimer’s Drug Donanemab, Expanding US Treatment Options
The FDA has approved Eli Lilly’s Alzheimer’s drug donanemab, branded as Kisunla, for early symptomatic adults, providing a new treatment option for nearly 7 million Americans affected by the disease.
Apple Joins OpenAI's Board: Phil Schiller Takes Observer Role in Historic Partnership
Apple has secured an observer role on OpenAI’s board as part of a significant agreement, with Phil Schiller, the head of Apple’s App Store, appointed to the position.
US Crude Oil Price Surges Due to Middle East Tensions and Hurricane Beryl
Escalating geopolitical tensions between Israel and Hezbollah and Hurricane Beryl's potential impact on Gulf Coast refineries push US crude oil prices to reach a two-month high.
Fintech Bankruptcy Locks Out 100,000 Americans With $265 Million in Deposits
The collapse of Synapse has left over 100,000 Americans with $265 million in deposits frozen since May 11, exposing flaws in fintech's reliance on third-party banking partnerships and prompting urgent calls for resolution from lawmakers.

















